Skip to Primary Navigation

FDA nominee backs vaccine safety, sidesteps abortion pill debate

FDA commissioner nominee Heidi Overton defended vaccine safety while declining to take firm positions on mifepristone reviews.

Article label: Quick Read
Premium article

President Donald Trump’s nominee to lead the FDA faced pointed questions from senators on vaccine safety and abortion drug regulation during her confirmation hearing.

Heidi Overton, MD, PhD, the nominee for FDA commissioner, emphasized that vaccines currently approved in the United States meet the agency’s standards for safety and effectiveness.

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 6,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience